SECURITIES AND EXCHANGE COMMISSION
                      Washington, D.C. 20549

                           FORM 10-K/A1


(Mark One)
[X]  Annual report pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934

              For the fiscal year ended May 25, 1997

                                or

[  ] Transition report pursuant to Section 13 or 15(d) of the Securities
     Exchange Act of 1934

For the transition period from             to

                  Commission File Number 1-11344

                INTERMAGNETICS GENERAL CORPORATION
---------------------------------------------------------------------------

      (Exact name of registrant as specified in its charter.)

                 New York                                     14-1537454
----------------------------------------------            ------------------
(State or other jurisdiction of incorporation              (I.R.S. Employer
             or organization)                             Identification No.)

         450 Old Niskayuna Road,
             Latham, New York                                    12110
----------------------------------------------                ----------
  (Address of principal executive offices)                     (Zip Code)

      Registrant's telephone number, including area code (518) 782-1122
                                                         ---------------

         Securities registered pursuant to Section 12(b) of the Act:

     Title of each class             Name of each exchange on which registered

Common Stock - $ .10 par value                  American Stock Exchange
--------------------------------            -------------------------------

         Securities registered pursuant to Section 12(g) of the Act:

                                     None
                            ----------------------
                               (Title of Class)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to
such filing requirements for the past 90 days.

                                 YES   X       NO
                                     -----        ------

Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of regulation S-K is not contained herein, and will not be contained,
to the best of the registrant's knowledge, in definitive proxy or
information statements in Part III of this Form 10-K or any amendment to
this Form 10-K.  [X]

The aggregate market value of the voting stock held by non-affiliates of
the registrant is approximately $116,758,808.  Such aggregate market value
was computed by reference to the closing price of the Common Stock as
reported on the American Stock Exchange on August 15, 1997.  It assumes
that all directors and officers of the registrant are affiliates.  In
making such calculation, the registrant does not determine whether any
director, officer or other holder of Common Stock is an affiliate for any
other purpose.

The number of shares of the registrant's Common Stock outstanding as of
August 15, 1997 was 12,457,034.

                     DOCUMENTS INCORPORATED BY REFERENCE

The information required for Part III hereof is incorporated by reference
from the registrant's Proxy Statement for its 1997 Annual Meeting of
Shareholders to be filed within 120 days after the end of the registrant's
fiscal year.
<PAGE>
PART IV.

ITEM 14.  EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K.

               (a)  FINANCIAL STATEMENTS, SCHEDULES AND EXHIBITS.

Attached hereto and filed as part of this report are the financial
statements, schedules and the exhibits listed below.

1.   Financial Statements

     *Reports of Independent Auditors

     *Consolidated Balance Sheets as of May 25, 1997 and May 26, 1996

     *Consolidated Statements of Income for the fiscal years ended May
      25, 1997, May 26, 1996 and May 28, 1995

     *Consolidated Statements of Shareholders' Equity for the fiscal
      years ended May 25, 1997, May 26, 1996 and May 28, 1995

     *Consolidated Statements of Cash Flows for the fiscal years ended
      May 25, 1997, May 26, 1996 and May 28, 1995

     *Notes to Consolidated Financial Statements

2.   Schedule

     II   Valuation and Qualifying Accounts

     All other schedules are not required or are inapplicable and,
therefore, have been omitted.

3.   Exhibits

Articles of Incorporation and By-laws

     3(i)  Restated Certificate of Incorporation (3) (Exhibit 3.1)

     3(ii) By-laws, as amended (4) (Exhibit 3.2)

Instruments defining the rights of security holders, including indentures

     4.1   Form of Common Stock certificate (6) (Exhibit 4.1)

     4.2   Amended and Restated Loan Agreement dated as of December 23, 1991
           among Meridian Bank, Intermagnetics General Corporation, APD
           Cryogenics Inc., Magstream Corporation and IGC Advanced
           Superconductors Inc. (6) (Exhibit 4.3)

     4.3   First Amendment dated as of February 26, 1992 to the Amended and
           Restated Loan Agreement dated as of December 23, 1991 among
           Meridian Bank, Intermagnetics General Corporation, APD Cryogenics
           Inc., Magstream Corporation and IGC Advanced Superconductors Inc.
           (6) (Exhibit 4.4)

     4.4   Second Amendment dated as of June 14, 1994 to the Amended and
           Restated Loan Agreement dated as of December 23, 1991 among
           Meridian Bank, Intermagnetics General Corporation, APD Cryogenics
           Inc. and Magstream Corporation. (8)

     4.5   Third Amendment dated as of August 1, 1994 to the Amended and
           Restated Loan Agreement dated as of December 23, 1991 among
           Meridian Bank, Intermagnetics General Corporation, APD Cryogenics
           Inc. and Magstream Corporation. (8)

Material Contracts

     10.1  Agreement Restating and Superseding Lease and Granting Rights to
           Use Common Areas and Other Rights dated as of December 23, 1991
           between Waterbury Industrial Commons Associates, IGC Advanced
           Superconductors Inc. and Intermagnetics General Corporation (6)
           (Exhibit 10.1)

   + 10.2  1990 Stock Option Plan (5) (Appendix A)

   + 10.3  1981 Stock Option Plan, as amended (2) (Exhibit 10.7)

   + 10.4  Supplemental Executive Benefit Agreement (1) (Exhibit 10.37)

     10.5  Agreement dated June 2, 1992 between Philips Medical Systems
           Nederlands B.V. and Intermagnetics General Corporation for sales
           of magnet systems (9) (Exhibit 10.6)

   # 10.6  Amendment No. 3 to the Agreement of June 2, 1992 between
           Philips Medical Systems Nederlands B.V. and Intermagnetics
           General Corporation for sales of magnet systems.  (Portions of
           this Exhibit have been omitted and have been filed separately
           with the Secretary of the Securities and Exchange Commission
           pursuant to an Application for Confidential Treatment under Rule
           24b-2 of the Securities Exchange Act of 1934, as amended.)

   + 10.7  Employment Agreement between Intermagnetics General
           Corporation and Carl H. Rosner (6)

     10.8  Share Purchase Agreement, dated January 23, 1992, by and between
           Ultralife Batteries, Inc. and Intermagnetics General Corporation
           (7) (Exhibit 10.1)

Subsidiaries of the registrant

     *21   Subsidiaries of the Company

           Consents of experts and counsel

     *23   Consent of KPMG Peat Marwick LLP with respect to the Registration
           Statements Numbers 2-80041, 2-94701, 33-2517, 33-12762, 33-12763,
           33-38145, 33-44693, 33-50598, 33-55092, 33-72160 and 333-10553 on
           Form S-8.

     (1)   Exhibit incorporated herein by reference to the Registration
           Statement on Form S-2 (Registration No. 2-99408) filed by the
           Company on August 2, 1985.

     (2)   Exhibit incorporated herein by reference to the Annual Report on
           Form 10-K filed by the Company for the fiscal year ended May 31,
           1997.

     (3)   Exhibit incorporated herein by reference to the Annual Report on
           Form 10-K filed by the Company for the fiscal year ended May 28,
           1989.

     (4)   Exhibit incorporated herein by reference to the Annual Report on
           Form 10-K filed by the Company for the fiscal year ended May 27,
           1990.

     (5)   Exhibit incorporated herein by reference to the Proxy Statement
           dated October 4, 1991 for the 1991 Annual Meeting of
           Shareholders.

     (6)   Exhibit incorporated herein by reference to the Annual Report on
           Form 10-K filed by the Company for the fiscal year ended May 31,
           1992, as amended by Amendment No. 1 on Form 8 dated November 17,
           1992.

     (7)   Exhibit incorporated herein by reference to the Quarterly Report
           on Form 10-Q filed by the Company for the six months ended
           November 29, 1992.

     (8)   Exhibit incorporated herein by reference to the Annual Report on
           Form 10-K for the fiscal year ended May 29, 1994.

     (9)   Exhibit incorporated herein by reference to the Annual Report on
           Form 10-K/A2 for the fiscal year ended May 29, 1994.  Portions of
           this Exhibit were omitted and filed separately with the Secretary
           of Securities and Exchange Commission pursuant to an Application
           for Confidential Treatment under Rule 24b-2 of the Securities
           Exchange Act of 1934, as amended.

*    Filed with the Annual Report on Form l0-K for the fiscal year ended
     May 25, 1997.

+    Management contract or compensatory plan or arrangement required to be
     filed as an exhibit to the Annual Report on Form 10-K.

#    Filed herewith.

     The Company agrees to provide the SEC upon request with copies of
certain long-term debt obligations which have been omitted pursuant to the
applicable rules.

     The Company agrees to furnish supplementally a copy of omitted
Schedules and Exhibits, if any, with respect to Exhibits listed above upon
request.

     (b)  REPORTS ON FORM 8-K

     Current Report on Form 8-K, filed March 7, 1997, in connection with
Corporate revenues and earnings through the Company's third quarter ended
February 23, 1997, and information with respect to the agreement in
principle for the acquisition, changes in the FRIGC refrigerant distributor
terms with Pennzoil Products, Co., the supply of FRIGC refrigerant by
AlliedSignal Inc., the extension of a major supply agreement for Magnet
products with Philips Medical Systems.

     Current Report on Form 8-K, filed March 21, 1997, in connection with
the merger on March 11, 1997 of Medical Advances, Inc. ("MAI") into
Intermagnetics Merger Sub, Inc., a wholly-owned subsidiary of
Intermagnetics General Corporation, including financial statements of MAI
and pro financial information filed, pursuant to a Confidential Treatment
Request, by Amendment on May 23, 1997.
<PAGE>
                            SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.

                              INTERMAGNETICS GENERAL CORPORATION

Date:  January 21, 1998       By:  /s/ Michael C. Zeigler
                                   ---------------------------------
                                   Michael C. Zeigler
                                   Senior Vice President - Finance;
                                   Chief Financial Officer

     Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of the
Registrant and in the capacities and on the date indicated.


 Name                               Capacity                          Date
------                             ----------                        ------


/s/ Michael C. Zeigler*         Chairman, President,
--------------------------      Chief Executive Officer
     Carl H. Rosner             (principal executive officer)
                                and Director


/s/ Michael C. Zeigler          Senior Vice President-
---------------------------     Finance; Chief Financial
    Michael C. Zeigler          Officer (principal financial
                                and accounting officer)


/s/ Michael C. Zeigler*         Director
---------------------------
     Joseph C. Abeles


/s/ Michael C. Zeigler*         Director
---------------------------
     John M. Albertine


/s/ Michael C. Zeigler*         Director
---------------------------
   Edward E. David, Jr.


/s/ Michael C. Zeigler*         Director
---------------------------
     Jack E. Goldman


/s/ Michael C. Zeigler*         Director
---------------------------
  Thomas L. Kempner


/s/ Michael C. Zeigler*         Director
---------------------------
     Stuart A. Shikiar


/s/ Michael C. Zeigler*         Director
---------------------------
      Sheldon Weinig


*By:  /s/ Michael C. Zeigler*                             January 21, 1998
      ---------------------------------------
          Michael C. Zeigler, Attorney-in-fact
<PAGE>
                                  EXHIBIT INDEX

EXHIBIT NUMBER     DESCRIPTION                                      LOCATION

     10.6          Amendment No. 3 to the Agreement of June       Filed Herewith
                   2, 1992 between Philips Medical Systems
                   Nederlands B.V. and Intermagnetics General
                   Corporation for sales of magnet systems.
                   (Portions of this Exhibit have been omitted
                   and have been filed separately with the
                   Secretary of the Securities and Exchange
                   Commission pursuant to an Application for
                   Confidential Treatment under Rule 24b-2 of
                   the Securities Exchange Act of 1934, as 
                   amended.)